• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » T2 Biosystems’ T2MR detects Lyme disease-causing bacteria in blood

T2 Biosystems’ T2MR detects Lyme disease-causing bacteria in blood

June 1, 2017 By Sarah Faulkner

Canon USA, T2 BiosystemsT2 Biosystems Inc. (NSDQ:TTOO) touted data today showing that its miniaturized magnetic resonance diagnostic tech can detect Lyme disease-causing bacteria in clinical blood samples. The preclinical study was published in the Journal of Clinical Microbiology. 

The Lexington, Mass.-based company, in partnership with Canon USA, said it expects to wrap up preclinical studies for its T2Lyme Panel this year, followed by a clinical trial for FDA submission in 2018.

“This study shows strong evidence that Lyme disease-causing bacteria exist transiently in blood,” co-author Dr. Thomas Fritsche said in prepared remarks. “T2MR is the only technology proven sensitive enough to directly detect these bacteria.”

Traditionally, researchers use serology to diagnose Lyme disease by detecting antibodies that are triggered by the disease. There is no FDA-approved diagnostic based on direct measurement of Lyme disease-causing bacteria.

Regulatory agencies recommend a 2-tiered approach to diagnose Lyme disease, but the technique detects 2 antibodies that require 1-2 weeks and 4-6 weeks to reach detectable levels, leaving a window where diagnosis of early Lyme disease is not possible.

T2MR detected both confirmed cases of Lyme disease tested in the study, as well as 17 samples from patients thought to have Lyme disease. The company’s diagnostic system outperformed conventional PCR methods, which only detected 1 case of of Lyme disease-causing bacteria.

Researchers also noted that T2’s system was much more analytically sensitive than conventional techniques.

“T2MR is a method to detect Lyme spirochetes in whole blood that promises rapid and reliable sample-to-answer results and this study offers insight to how this diagnostic may improve clinical care for individuals with Lyme disease,” co-author Steven Callister added.

Filed Under: Diagnostics, Wall Street Beat Tagged With: T2 Biosystems Inc.

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy